These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 7747363

  • 1. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
    Shiina H, Shirakawa H, Yokogi H, Kishi H, Mizutani M, Igawa M, Ishibe T.
    Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H, Urakami S, Shirakawa H, Shigeno K, Himeno Y, Mizutani M, Igawa M, Ishibe T.
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H, Igawa M, Urakami S, Shirakawa H, Ishibe T.
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [Abstract] [Full Text] [Related]

  • 4. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M, Shimazui T, Uchida K, Hinotsu S, Akaza H.
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [Abstract] [Full Text] [Related]

  • 5. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A, Chiusa L, Margaria E.
    Cancer Detect Prev; 1995 Jul; 19(3):282-91. PubMed ID: 7750118
    [Abstract] [Full Text] [Related]

  • 6. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
    Korneyev IA, Mamaev NN, Kozlov VV, Rybakova MG, al-Shukri SH.
    Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
    [Abstract] [Full Text] [Related]

  • 7. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
    Cucer N, Imamoglu N, Tozak H, Demirtas H, Sarac F, Tatlisen A, Oztürk F.
    Micron; 2007 Jun; 38(6):674-9. PubMed ID: 17011198
    [Abstract] [Full Text] [Related]

  • 8. Nucleolar and argyrophilic nucleolar organizer region counts in urothelial carcinomas with special emphasis on grade II tumors.
    Helpap B, Loesevitz L, Bulatko A.
    Virchows Arch; 1994 Jun; 425(3):265-9. PubMed ID: 7812512
    [Abstract] [Full Text] [Related]

  • 9. Ki-67 scores and AgNor counts in transitional cell carcinoma of the bladder: apparent lack of prognostic value.
    Zambelli S, Zanin A, Gaglio A, Zai G, Bosco E, Andrion A, Magnani C.
    Arch Ital Urol Androl; 1993 Dec; 65(6):665-70. PubMed ID: 8312949
    [Abstract] [Full Text] [Related]

  • 10. [Significance of AgNOR analysis of urothelial carcinomas].
    Helpap B, Loesevitz L.
    Verh Dtsch Ges Pathol; 1993 Dec; 77():222-5. PubMed ID: 7511285
    [Abstract] [Full Text] [Related]

  • 11. AgNOR count in resting cells (resting NOR) is a new prognostic marker in invasive bladder tumor.
    Tomobe M, Shimazui T, Uchida K, Akaza H.
    Anal Cell Pathol; 2001 Dec; 22(4):193-9. PubMed ID: 11564895
    [Abstract] [Full Text] [Related]

  • 12. Argyrophilic nucleolar organizer region counts predict survival in thymoma.
    Pich A, Chiarle R, Chiusa L, Palestro G.
    Cancer; 1994 Sep 01; 74(5):1568-74. PubMed ID: 7520349
    [Abstract] [Full Text] [Related]

  • 13. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A, Korkolopoulou P, Papanicolaou A, Christodoulou P, Thomas-Tsagli E, Pavlakis K.
    Eur Urol; 1992 Sep 01; 22(3):235-40. PubMed ID: 1361436
    [Abstract] [Full Text] [Related]

  • 14. AgNOR/P53 expression compared with different grades in bladder carcinoma.
    Karakök M, Aydin A, Bakir K, Uçak R, Korkmaz C.
    Int Urol Nephrol; 2001 Sep 01; 33(2):353-5. PubMed ID: 12092655
    [Abstract] [Full Text] [Related]

  • 15. High and low risk prostate carcinoma determined by histologic grade and proliferative activity.
    Chiusa L, Galliano D, Formiconi A, Di Primio O, Pich A.
    Cancer; 1997 May 15; 79(10):1956-63. PubMed ID: 9149023
    [Abstract] [Full Text] [Related]

  • 16. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
    Hansen AB, Bjerregaard B, Ovesen H, Horn T.
    Histopathology; 1992 Mar 15; 20(3):257-62. PubMed ID: 1563712
    [Abstract] [Full Text] [Related]

  • 17. Image analysis of Ag-NOR proteins in transitional cell bladder cancer.
    Lipponen P.
    J Pathol; 1993 Dec 15; 171(4):279-83. PubMed ID: 8158457
    [Abstract] [Full Text] [Related]

  • 18. Silver-stained nucleolar organizer regions (AgNORs) as a prognostic value in malignant melanoma.
    Barzilai A, Goldberg I, Yulash M, Pavlotsky F, Zuckerman A, Trau H, Azizi E, Kopolovic J.
    Am J Dermatopathol; 1998 Oct 15; 20(5):473-7. PubMed ID: 9790108
    [Abstract] [Full Text] [Related]

  • 19. Cathepsin B, p53 expression and AgNORs in transitional cell carcinoma.
    Akpolat I, Bariş YS, Yilmaz AF, Bakirtaş M, Saylik A, Karagöz F, Kandemir B.
    Neoplasma; 1998 Oct 15; 45(6):365-8. PubMed ID: 10210109
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
    Celikel C, Dillioğlugil O, Türkeri LN, Başaran M, Yalçiner A, Küllü S, Akdaş A.
    Eur Urol; 1995 Oct 15; 28(2):152-7. PubMed ID: 8529742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.